Position in NVS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$213,452
+$5,407 QoQ
Shares Held
1,362
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,288
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TrustBank holds $13,630,060 across 9 Drug Manufacturers - General names. NVS ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
31,187 | $7,847,896 | |
| 2 | LLY |
ELI LILLY & Co
|
2,453 | $2,942,202 | |
| 3 | AMGN |
Amgen Inc
|
2,739 | $991,846 | |
| 4 | JNJ |
Johnson & Johnson
|
3,306 | $839,624 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,013 | $387,170 | |
| 6 | NVS |
Novartis AG
This page
|
1,362 | $213,452 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,857 | $164,620 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,114 | $140,742 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,452 | 1,362 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $208,045 | 1,362 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $187,778 | 1,362 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||